A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

[1]  M. Hochberg,et al.  A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. , 2017, Osteoarthritis and cartilage.

[2]  A. Behfar,et al.  Mesenchymal stem cell therapy for osteoarthritis: current perspectives , 2015, Stem cells and cloning : advances and applications.

[3]  B. Chesworth,et al.  Weight-bearing asymmetry and vertical activity differences in a rat model of post-traumatic knee osteoarthritis. , 2015, Osteoarthritis and cartilage.

[4]  Yeon-Ju Lee,et al.  Type II collagen and glycosaminoglycan expression induction in primary human chondrocyte by TGF-β1 , 2015, BMC Musculoskeletal Disorders.

[5]  R. Nusse,et al.  An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.

[6]  Michael Kahn,et al.  Can we safely target the WNT pathway? , 2014, Nature Reviews Drug Discovery.

[7]  Raveendhara R. Bannuru,et al.  OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.

[8]  I. Sekiya,et al.  Mesenchymal Stem Cells in Synovial Fluid Increase After Meniscus Injury , 2013, Clinical orthopaedics and related research.

[9]  Jiyeon Kim,et al.  CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells , 2013, PloS one.

[10]  Krishna Dalal,et al.  Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: A novel diagnostic and prognostic biomarker , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  P. Vavken,et al.  Surgical management of osteoarthritis
 , 2013, Wiener Medizinische Wochenschrift.

[12]  Norio Nakatsuji,et al.  A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. , 2012, Cell reports.

[13]  I. Sekiya,et al.  Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  Peter G. Schultz,et al.  A Stem Cell–Based Approach to Cartilage Repair , 2012, Science.

[15]  Charles E McCulloch,et al.  Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. , 2012, Arthritis and rheumatism.

[16]  S. Krauss,et al.  Wnt/beta-Catenin Signaling and Small Molecule Inhibitors , 2012, Current pharmaceutical design.

[17]  E. Canalis,et al.  Nemo‐like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling , 2012, Journal of cellular biochemistry.

[18]  D. Chan,et al.  SOX9 Governs Differentiation Stage-Specific Gene Expression in Growth Plate Chondrocytes via Direct Concomitant Transactivation and Repression , 2011, PLoS genetics.

[19]  R. O’Keefe,et al.  BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development , 2011, Journal of Cell Science.

[20]  R. Dasgupta,et al.  An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway , 2011, Proceedings of the National Academy of Sciences.

[21]  Z-H Shi,et al.  New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. , 2011, Current medicinal chemistry.

[22]  Hui Wang,et al.  Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits , 2010, Experimental & Molecular Medicine.

[23]  C. Little,et al.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.

[24]  R. Fuller,et al.  Osteoarthritis: can anti-cytokine therapy play a role in treatment? , 2010, Clinical Rheumatology.

[25]  Chun-yan Zhou,et al.  Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes. , 2009, Arthritis and rheumatism.

[26]  P. Emery,et al.  Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. , 2008, Arthritis and rheumatism.

[27]  R. Nusse.  Wnt signaling and stem cell control , 2008, Cell Research.

[28]  J. Simon,et al.  A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities , 2008, Molecular Cancer Therapeutics.

[29]  C. Walsh,et al.  Doublecortin is expressed in articular chondrocytes. , 2007, Biochemical and biophysical research communications.

[30]  B. Johnstone,et al.  Ascorbate-enhanced chondrogenesis of ATDC5 cells. , 2006, European cells & materials.

[31]  Xi He,et al.  Adenomatous Polyposis Coli (APC) Differentially Regulates β-Catenin Phosphorylation and Ubiquitination in Colon Cancer Cells* , 2006, Journal of Biological Chemistry.

[32]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Chondrogenesis in a Context-dependent Manner* , 2006, Journal of Biological Chemistry.

[33]  H. Roca,et al.  BMP Signaling Is Required for RUNX2‐Dependent Induction of the Osteoblast Phenotype , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  M. Nevitt,et al.  Frizzled-related protein variants are risk factors for hip osteoarthritis. , 2006, Arthritis and rheumatism.

[35]  L. Duong,et al.  Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. , 2006, Bone.

[36]  S. Jimenez,et al.  Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.

[37]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[38]  D. Rice,et al.  Chondrogenic Potential of Mouse Calvarial Mesenchyme , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  E. Vignon,et al.  Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. , 2004, Osteoarthritis and cartilage.

[40]  T. Underhill,et al.  MAP kinases in chondrocyte differentiation. , 2003, Developmental biology.

[41]  Brendan H. Lee,et al.  Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte–specific expression in vivo , 2003, The Journal of cell biology.

[42]  F. De Ceuninck,et al.  Quantitative assessment of articular cartilage and subchondral bone histology in the meniscectomized guinea pig model of osteoarthritis. , 2003, Osteoarthritis and cartilage.

[43]  W. English,et al.  Matrix metalloproteinases in arthritic disease , 2002, Arthritis research.

[44]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[45]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[46]  L. Solomon.  Pathogenesis of osteoarthritis. , 1972, Lancet.

[47]  A. Mikos,et al.  TGF-β3-induced chondrogenesis in co-cultures of chondrocytes and mesenchymal stem cells on biodegradable scaffolds. , 2014, Biomaterials.

[48]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis & Rheumatism.

[49]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.